Researchers to develop new drug delivery systemNovember 14th, 2007 - 8:25 am ICT by admin
In Hunter syndrome, for example, patients are lacking the enzyme iduronate-2-sulfatase that helps cells break down certain waste products. One in every 130,000 boys is born with the rare but deadly genetic disorder.
Zappe said that he selected adult neural stem cells for his work because they can be harvested from a patient’s brain, have the potential to be multiplied outside of the body, can be genetically engineered, can disperse within the brain once re-implanted and can replace all major cell types of the brain.
In order to support the therapeutic goals, Zapp and his research team have created cell-instructive microcapsules that contain neural stem cells. These microcapsules efficiently control whether stem cells proliferate (multiply), differentiate into more specialized cell types like neurons and to what extent implanted stem cells will be allowed to migrate to the host tissue.
Zappe will be using these caviar-sized capsules specifically for rapid manipulation of stem cells outside the body and for reliable delivery of stem cells to the brain.
The acute inflammatory response that usually occurs from implantation would normally cause implanted neural stem cells to differentiate into mature cell types that are not able to migrate extensively. Encapsulated stem cells will be protected from such premature differentiation.
Once the brain has healed from the initial implant of the encapsulated stem cells, the stem cells are genetically engineered to produce an enzyme that eats the microcapsule, freeing the neural stem cells. The stem cells can then migrate deep into the surrounding brain tissue where they provide the missing enzyme.
“We are particularly interested in targeting the brain because this area of the body is protected by the so-called blood-brain barrier that has been very difficult to penetrate with therapeutic enzymes that are usually injected into the patient’s bloodstream,” Zappe said.
The research team is working to develop technologies that will ultimately enable clinicians to harvest neural stem cells from a patient, genetically engineer them from outside the body and then re-implant them and remotely control their actions in non-invasive ways.
“By using inducible gene expression, we hope to provide physicians with external control over capsule degradation and the amount of therapeutic enzyme released into the brain by engineered cells as determined by the dose of drugs that are given to the patient in pill form,” Zappe said.
“Hunter syndrome is a devastating illness affecting more than 500 children in the U.S. alone. Over time, toxic waste products accumulate in the cells of the body, and, although progression of the disease varies, the majority of children die in their teens,” Dr. Raymond Sekula, a neurosurgeon at Allegheny General Hospital, co-author of the study, said.
If we can reliably provide the missing enzyme iduronate-2-sulfatase to the central nervous system of these children, we may change the course of this disease. Our technology and methodology also will likely have far-reaching implications for hundreds of other diseases of the central nervous system,” Sekula added. (ANI)
- How to keep stem cells 'forever young' - Dec 29, 2009
- New research offers hope to Parkinson's disease patients - Feb 09, 2011
- Fuel cells developed that may help paralysed move - Jun 14, 2012
- Adult stem cells that do not age created - Oct 02, 2010
- Discovery of key pathway interaction paves way for brain growth therapies - Sep 17, 2010
- Nanotechnology could help smuggle drugs into the gut - Nov 05, 2010
- Stem cell implants can heal traumatic brain injury - Jan 16, 2012
- Human neural stem cells 'can restore mobility in chronic spinal cord injury cases' - Aug 20, 2010
- Surgeons conduct north India's first cartilage transplant - Nov 13, 2011
- Research may pave way for new regenerative therapies - May 04, 2011
- Frog embryos may harbour human heart health secrets - Apr 24, 2011
- Diabetes drug spurs growth of brain cells - Jul 06, 2012
- Patients' own cells 'may shed light into schizophrenia causes' - Apr 14, 2011
- Novel cell therapy slows down vision loss in eye disease - Apr 08, 2011
- Some nerve! Now bypass stem cells - Feb 01, 2012
Tags: acute inflammatory response, adult, brain tissue, carnegie mellon, drug delivery system, encapsulated, genetic disorder, genetically engineered, host tissue, hunter syndrome, multiply, proliferate, stem cells, therapeutic goals, waste products, zapp